Loading...
Sarepta Therapeutics, Inc.
SRPT•NASDAQ
Healthcare
Biotechnology
$11.93
$-0.95(-7.38%)
Sarepta Therapeutics, Inc. (SRPT) Financial Performance & Income Statement Overview
Review Sarepta Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
52.97%
↑ 52.97%
Operating Income Growth
181.43%
↑ 181.43%
Net Income Growth
143.89%
↑ 143.89%
Operating Cash Flow Growth
58.92%
↑ 58.92%
Operating Margin
-5.25%
↓ 5.25%
Gross Margin
80.96%
↑ 80.96%
Net Profit Margin
-11.12%
↓ 11.12%
ROE
-20.00%
↓ 20.00%
ROIC
-4.10%
↓ 4.10%
Sarepta Therapeutics, Inc. (SRPT) Income Statement & Financial Overview
Review Sarepta Therapeutics, Inc.'s (SRPT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $658.41M | $467.17M | $362.93M | $413.46M |
| Cost of Revenue | $132.30M | $91.69M | $53.26M | $50.56M |
| Gross Profit | $526.11M | $375.48M | $309.67M | $362.90M |
| Gross Profit Ratio | $0.80 | $0.80 | $0.85 | $0.88 |
| R&D Expenses | $199.95M | $224.48M | $173.71M | $194.35M |
| SG&A Expenses | $163.87M | $128.20M | $136.66M | $127.003M |
| Operating Expenses | $364.43M | $353.29M | $310.37M | $328.00M |
| Total Costs & Expenses | $496.73M | $444.98M | $363.63M | $378.56M |
| Interest Income | $14.70M | $18.33M | $18.84M | $19.90M |
| Interest Expense | $4.47M | $4.92M | $4.83M | $4.17M |
| Depreciation & Amortization | $10.46M | $9.81M | $12.73M | $12.70M |
| EBITDA | $186.67M | $48.73M | $12.03M | $58.31M |
| EBITDA Ratio | $0.28 | $0.10 | $0.03 | $0.16 |
| Operating Income | $161.68M | $22.20M | -$701000.00 | $34.91M |
| Operating Income Ratio | $0.25 | $0.05 | -$0.002 | $0.08 |
| Other Income/Expenses (Net) | $10.06M | $11.81M | $14.28M | $6.54M |
| Income Before Tax | $171.74M | $34.006M | $13.58M | $41.45M |
| Income Before Tax Ratio | $0.26 | $0.07 | $0.04 | $0.10 |
| Income Tax Expense | $12.69M | $395000.00 | $7.12M | $5.33M |
| Net Income | $159.05M | $33.61M | $6.46M | $36.12M |
| Net Income Ratio | $0.24 | $0.07 | $0.02 | $0.09 |
| EPS | $1.65 | $0.35 | $0.07 | $0.38 |
| Diluted EPS | $1.47 | $0.33 | $0.07 | $0.37 |
| Weighted Avg Shares Outstanding | $96.28M | $95.39M | $94.62M | $93.99M |
| Weighted Avg Shares Outstanding (Diluted) | $108.47M | $100.45M | $94.62M | $99.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan